APB-R5

N/A

Report date: 2024/11/14 14:41:24
NME

Base Information

Drug NameAPB-R5
Drug Alias NameAPB-R5
ClassificationSmall molecules
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAprilBio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAprilBio Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A